UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 166 filers reported holding UNIQURE NV in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,309,121 | +44.4% | 195,100 | +387.8% | 0.10% | +47.8% |
| Q4 2022 | $906,800 | -19.5% | 40,000 | -33.3% | 0.07% | -18.8% |
| Q3 2022 | $1,126,000 | -17.7% | 60,000 | -18.3% | 0.08% | -9.6% |
| Q2 2022 | $1,368,000 | -3.5% | 73,396 | -6.4% | 0.09% | -3.1% |
| Q1 2022 | $1,417,000 | -12.9% | 78,396 | 0.0% | 0.10% | +3.2% |
| Q4 2021 | $1,626,000 | -19.9% | 78,396 | +23.7% | 0.09% | -12.1% |
| Q3 2021 | $2,029,000 | -30.5% | 63,396 | -33.1% | 0.11% | -24.1% |
| Q2 2021 | $2,920,000 | -21.8% | 94,790 | -14.4% | 0.14% | +1.4% |
| Q1 2021 | $3,733,000 | -36.5% | 110,790 | -31.9% | 0.14% | -33.5% |
| Q4 2020 | $5,878,000 | -55.2% | 162,700 | -54.3% | 0.21% | +8.9% |
| Q3 2020 | $13,118,000 | +505.9% | 356,200 | +547.6% | 0.19% | +392.3% |
| Q3 2019 | $2,165,000 | – | 55,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |